LDLR and atherosclerosis: LDL-receptor deficient mice exposed to recombinant IFN-α develop worsening hyperlipidemia and atherosclerosis, while recent evidence points at a deleterious role of another type I IFN, IFN-β, in murine atherosclerosis [42], [43].